453 / 670
$2$& ,17(51$7,21$/
$2$& 6035
6WDQGDUG 0HWKRG 3HUIRUPDQFH 5HTXLUHPHQWV
IRU 'HWHUPLQDWLRQ RI )OXRULGH LQ ,QIDQW DQG
$GXOW 3HGLDWULF 1XWULWLRQDO )RUPXOD
,QWHQGHG 8VH 5HIHUHQFH 0HWKRG IRU 'LVSXWH 5HVROXWLRQ
1 Applicability
'HWHUPLQDWLRQ RI
ÀXRULGH
LQ DOO IRUPV RI LQIDQW DGXOW DQG
RU SHGLDWULF IRUPXOD SRZGHUV UHDG\ WR IHHG OLTXLGV DQG OLTXLG
FRQFHQWUDWHV
2 Analytical Technique
$Q\ DQDO\WLFDO WHFKQLTXH WKDW PHHWV WKH IROORZLQJ PHWKRG
SHUIRUPDQFH UHTXLUHPHQWV LV DFFHSWDEOH
3 Definitions
Accuracy (corresponds to the VIM definition for “trueness”)
²
7KH FORVHQHVV RI DJUHHPHQW EHWZHHQ WKH DYHUDJH RI DQ LQ¿QLWH
QXPEHU RI UHSOLFDWH PHDVXUHG TXDQWLW\ YDOXHV DQG D UHIHUHQFH
TXDQWLW\ YDOXH
Adult/pediatric formula.
²1XWULWLRQDOO\ FRPSOHWH VSHFLDOO\
IRUPXODWHG IRRG FRQVXPHG LQ OLTXLG IRUP ZKLFK PD\ FRQVWLWXWH
WKH VROH VRXUFH RI QRXULVKPHQW >$2$& 6WDNHKROGHU 3DQHO RQ ,QIDQW
)RUPXOD DQG $GXOW 1XWULWLRQDOV 63,)$1 @ PDGH IURP DQ\
FRPELQDWLRQ RI PLON VR\ ULFH ZKH\ K\GURO\]HG SURWHLQ VWDUFK
DQG DPLQR DFLGV ZLWK DQG ZLWKRXW LQWDFW SURWHLQ
Fluoride
²
7KH DQLRQ RU DQLRQLF VDOW FRPSRXQGV RI ÀXRULGH
) &$6 1R
Infant formula
²%UHDVW PLON VXEVWLWXWH VSHFLDOO\ PDQXIDFWXUHG
WR VDWLVI\ E\ LWVHOI WKH QXWULWLRQDO UHTXLUHPHQWV RI LQIDQWV GXULQJ
WKH ¿UVW PRQWKV RI OLIH XS WR WKH LQWURGXFWLRQ RI DSSURSULDWH
FRPSOHPHQWDU\ IHHGLQJ &RGH[ 6WDQGDUG ±
PDGH IURP
DQ\ FRPELQDWLRQ RI PLON VR\ ULFH ZKH\ K\GURO\]HG SURWHLQ
VWDUFK DQG DPLQR DFLGV ZLWK DQG ZLWKRXW LQWDFW SURWHLQ
Limit of quantitation (LOQ)
²7KH PLQLPXP FRQFHQWUDWLRQ
RU PDVV RI DQDO\WH LQ D JLYHQ PDWUL[ WKDW FDQ EH UHSRUWHG DV D
TXDQWLWDWLYH UHVXOW
Repeatability
²9DULDWLRQ DULVLQJ ZKHQ DOO HIIRUWV DUH PDGH
WR NHHS FRQGLWLRQV FRQVWDQW E\ XVLQJ WKH VDPH LQVWUXPHQW DQG
RSHUDWRU DQG UHSHDWLQJ GXULQJ D VKRUW WLPH SHULRG ([SUHVVHG DV WKH
UHSHDWDELOLW\ VWDQGDUG GHYLDWLRQ 6'
U
RU UHSHDWDELOLW\ UHODWLYH
VWDQGDUG GHYLDWLRQ 56'
U
Reproducibility
²7KH VWDQGDUG GHYLDWLRQ RU UHODWLYH VWDQGDUG
GHYLDWLRQ FDOFXODWHG IURP DPRQJ ODERUDWRU\ GDWD ([SUHVVHG DV
WKH UHSURGXFLELOLW\ VWDQGDUG GHYLDWLRQ 6'
5
RU UHSURGXFLELOLW\
UHODWLYH VWDQGDUG GHYLDWLRQ 56'
5
4 Method Performance Requirements
See
7DEOH
5 System Suitability Tests and/or Analytical Quality Control
6XLWDEOH PHWKRGV ZLOO LQFOXGH EODQN FKHFN VDPSOHV DQG FKHFN
VWDQGDUGV DW WKH ORZHVW SRLQW DQG PLGUDQJH SRLQW RI WKH DQDO\WLFDO
UDQJH
6 Reference Material(s)
1HLWKHU 1,67 QRU ,550 SURGXFH D FHUWL¿HG UHIHUHQFH PDWHULDO
IRU ÀXRULGH LQ LQIDQW IRUPXOD 7KH ÀXRULGH FRQWHQW RI 650 D
KDV QRW EHHQ GHWHUPLQHG DV RI 1RYHPEHU
7 Validation Guidance
5HFRPPHQGHG OHYHO RI YDOLGDWLRQ
Official Methods of
Analysis
60
8 Maximum Time-to-Result
1R PD[LPXP WLPH
Approved by Stakeholder Panel on Infant Formula and Adult
Nutritionals (SPIFAN). Final Version Date: September 6, 2014.
Effective Date: October 23, 2014.
7DEOH 0HWKRG SHUIRUPDQFH UHTXLUHPHQWV
a
3DUDPHWHU
0LQLPXP DFFHSWDEOH FULWHULD
$QDO\WLFDO UDQJH
±
b
/LPLW RI TXDQWLWDWLRQ /24
b
5HFRYHU\
±
±
±
±
5HSHDWDELOLW\ 56'
U
±
±
5HSURGXFLELOLW\ 56'
5
±
±
a
&RQFHQWUDWLRQV DSSO\ WR
a
µUHDG\ WR IHHG´ OLTXLGV ³DV LV´
b
UHFRQVWLWXWHG SRZGHUV J LQWR J GHLRQL]HG ZDWHU DQG
c
OLTXLG FRQFHQWUDWHV GLOXWHG E\ ZHLJKW ZLWK GHLRQL]HG ZDWHU
b
ȝJ J UHFRQVWLWXWHG ¿QDO SURGXFW